Serum levels of tumor necrosis factor-alpha and vascular endothelial growth factor as markers of disease activity in patients with axial spondyloarthritis
Background: Assessment of disease activity in axial spondyloarthritis (axSpA) has remained a challenge. This study aims to investigate the role of vascular endothelial growth factor (VEGF) and tumor necrosis factor-alpha (TNF-α) as markers of disease activity in patients with axSpA. Methods: A to...
Saved in:
| Main Authors: | Mahendran Bhuvanesh, Chilkuri Balaji, Chinnadurai Saranya, Ramamoorthy Ramesh, Trichangode Natesan Tamilselvam, Sankaralingam Rajeswari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=1;spage=9;epage=13;aulast=Bhuvanesh |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ankylosing Spondilitis in a Patient with Hepatitis Reactivation Treated with Anti-tumor Necrosis Factor Alpha: A Case Report
by: Emine Unkun Kandemir, et al.
Published: (2024-12-01) -
Development of thymoma without myasthenia gravis in a patient with radiographic axial spondyloarthritis treated with tumor necrosis factor-α inhibitors
by: Piera Altieri, et al.
Published: (2025-06-01) -
Behcet's disease concurrent with axial spondyloarthritis: the authors' own observations
by: Z. S. Alekberova, et al.
Published: (2019-11-01) -
Microbiome dysbiosis in spinal pathology: Mechanisms, evidence, and research limitations
by: Muaz Rashid, et al.
Published: (2025-01-01) -
TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)